The 9th edition of the World Heart Summit will be held in Geneva, Switzerland — the heart of global health diplomacy — on 24-26 May 2024, ahead of the 77th World Health Assembly.
Trailblazers across government, business, civil society and academia will come together to tackle some of today’s most pressing global challenges in cardiovascular health.
Together, we can pave the way to a brighter, healthier future for all.
On the Thursday and Friday prior to the Summit, WHF will be hosting a series of events for our community, leadership and volunteers.
Multimorbidity and Integrated Care Forum (Invitation only)
Multimorbidity and Integrated Care Forum (Invitation only)
WHF Committee Meetings (WHF Committees)
WHF Spring Meeting (WHF Board and Committees)
Meet & Share Forum
Summit Welcome Reception
Welcome & Registration
Welcome and Introduction to the Summit
Opening plenary introduction
Opening plenary: Cardiovascular health and environmental change: A vital nexus
Health and climate change are inextricably linked: Rising temperatures and poor air quality can worsen cardiovascular and respiratory conditions, while extreme heat can also lead to heat-related illnesses. This opening plenary will focus on:
The perspective from LMICs, that are the most impacted by extreme weather events resulting in negative health outcomes, to amplify messaging around the urgency of addressing the climate crisis.
Ministerial panel: Closing the gap in Universal Health Coverage and health financing for CVD
Achieving UHC is essential in addressing the global burden of cardiovascular disease. CVD is a major driver of out-of-pocket health expenditure, leading to poverty and undermining development. This Ministerial panel will showcase examples from countries in different regions that scaled up efforts to achieve UHC, highlighting country strategies to boost financing for NCDs and particularly CVD, discussing challenges experienced in the process, but also demonstrating that it is not an unattainable goal.
Break
Panel discussion: Diverse health system approaches: From theory to real-life implementation and scale-up
Cardiovascular disease, including ischemic heart disease, congenital heart disease and RHD, among other conditions, require a comprehensive health system approach to ensure sustainable lifelong care at all levels of the health system, which is integrated with other services or spaces in the community. This session will start discussing common obstacles undermining the management of common CVD, ranging from delayed diagnosis, to missed opportunities for screening, minimal access to therapeutics, interventions and surgeries, lack of long term follow up and care, as well as awareness raising and advocacy. The discussion will focus on:
Examples of how such approaches have been successfully implemented in different contexts and address implementation challenges that may arise when scaling up.
Lunch
Morning sessions recap and introduction to the afternoon sessions
Panel discussion: Addressing social determinants: Paving the way for improved cardiovascular health
Factors beyond genetics influence the heart health of individuals and communities. The so-called determinants of health include socio-economic condition, individual behaviours, environmental and commercial factors.
This session will discuss:
Approaches to reduce racial and ethnic disparities in CV health.
Break
Debate format session: AI in cardiovascular health: Opportunities and threats
This debate session will feature two opposing viewpoints on AI deployment in CV health:
• The first view will illustrate the different benefits of leveraging the AI potential in CV health in both HICs and LMICs, ranging from improved diagnostics, potential risk prediction and improved patient outcomes through precision medicine and personalized treatment plans.
• The opposing view will instead present the risks that such technologies pose to health care, including issues of ethics and privacy, potential erosion of the patient-provider relationship and the risk that excessive focus on AI might divert resources from other critical aspects of healthcare, as well as their limitations.
Panel discussion:Breaking through: Communications in an era of plenty
The growth of virtual platforms has been a blessing and a curse in many respects. While it is tempting to focus on the scourge of fake news, we must recognise that there are other challenges, some as basic as revisiting the importance of speaking about health and equity, of understanding who has the power to influence and change things for the better and meeting them where they are. This session gives WHF, partners, stakeholders, and others much food for thought and the impetus to build on strong foundations.
Summit Gala dinner
Welcome and introduction to the Summit second day
The dual burden of CVD and mental health
The connection between CVD and mental health is a critical area of concern and yet remains still inexplored. The aim of this session is to:
• Explore the scientific evidence and mechanisms linking depression and anxiety to elevated risks of CVD, including stroke and ischemic heart disease.
• Discuss the interplay between addiction to harmful substances, between tobacco and alcohol, and their impact on cardiovascular health.
• Discuss public health policies and strategies for healthcare providers to screen for CVD risk in people experiencing mental health disorders and effectively address the two silent killers.
Joint session with WHO on HEARTS Technical package: current and future considerations for implementation
The WHO HEARTS Technical Package serves as a comprehensive guide for improving cardiovascular care. In this session, we will dissect the current state of HEARTS implementation in different regions, highlighting challenges and obstacles, but also examples of success. We will also have a more forward-looking discussion, discussing the evolving landscape of HEARTS and its relevance in the context of technological innovations and how it can stay ahead in the ever-evolving field of cardiovascular health.
Break
Panel discussion: Her heart matters: Advancing women’s cardiovascular health
This session will discuss gender-specific risk factors for CVD, as well as challenges related to diagnostics and treatment approaches that are specific to women.
• It will highlight that underrepresentation of women in clinical studies is a root cause for the current evidence and practice gaps, undermining cardiovascular management for women and resulting in negative health outcomes.
• It will seek to explain the reasons behind underrepresentation of women in clinical trials and suggest key actions that need to be implemented to ensured better inclusion of women in research.
• It will touch on healthcare disparities, particularly with regards to access and quality, including issues of underdiagnosis and undertreatment that are negatively impacting CVD outcomes.
Lunch and Walk a Heart
Meet us at the main entrance of the Biotech Campus at 13:30 for a 20-minute, heart-shaped walk through some key Geneva landmarks. The walk is suitable for everyone.
Morning sessions recap and introduction to afternoon sessions
Panel discussion: The triple threat of CVD, climate change and ultra processed food
The consumption of ultra processed food (UPF) represents a major risk factor for two of the biggest challenges of our times: CVD and climate change. The production of UPF contributes considerably to deforestation and greenhouse gas emissions, as well as water usage. At the same time, regular consumption of UPF has been linked to an increased risk of CVD, due to their unhealthy levels of harmful fats, sodium and added sugars, which may contribute to obesity, high blood pressure and other CVD risk factors.
• This session will highlight the interconnection between climate change, CVD and UPF consumption as a considerable contributing factor to both climate change and CVD.
• It will also showcase policies and strategies to decrease UPF consumption and demonstrate their benefits in both reducing CVD and mitigating the impact of climate change.
Break
Panel discussion: Charting the course to 2025: Navigating cardiovascular health priorities at the UNHLM on NCDs
The UN HLM on NCDs will be an opportunity for countries to reiterate and strengthen their commitment to addressing the epidemic of NCDs and approve a bolder Political Declaration, based on available evidence. The WHF will take this opportunity to present its advocacy campaign on prioritizing CVD in the 2025 UN HLM on NCDs and delve into the key challenges and priorities for CV health that lie ahead.
The discussion will also unpack strategies, share insights and propose collaborative actions to ensure CV health remains at the forefront of global NCD agendas.
Minister of Public Health
Qatar
Minister of Health
Argentina
Minister of Health
Ghana
Reader in Air Pollution and Healthster of Health
University of Edinburgh
Director Public Health Environment and Social Determinants
World Health Organization
Distinguished Professor of Public Health
Public Health Foundation of India
CEO and Co-Founder
DakshamA Health and Education
Principal, Health Policy and Insights
The Economist Impact
Past-President
European Society of Cardiology
CEO
Inspire Health Solutions, LLC
Co-Founder & CEO
WHO Framework Convention on Tobacco Control
-,Past-President
American College of Cardiology
Executive Director
Kenya NCD Alliance
Director
Heart and Mind Wellbeing Center
Professor of Cardiac Psychology
East Carolina University
sityCVD Patient Advocate and Comedian
Emeritus Professor in Cardiology
Imperial College London
CEO
WomenHeart
Advisor, Nutrition and Physical Activity
PAHO
Professor, Nutritional Sciences
King’s College London
Head of Global Development and Advocacy
World Diabetes Foundation
Professor, Department of Clinical Science
University of Bergen
Executive Director
Global Alliance for Tobacco Control
Executive Director
Global Heart Hub
Vice President
World Heart Federation
Head, Division of Disease Control and Prevention
AfricaCDC
Founder
Brave Heart, Lebanon
Professor and Chair of Cardiology
University of Cape Town
Founder and CEO
Daktari Africa
CEO
I-DAIR
Chief Science and Medical Officer
American Heart Association
Chief Action Officer
EAT
Situated between Lake Geneva and the Swiss-French mountains, the city of Geneva is home to the world’s highest concentration of international organizations and diplomatic missions. It hosts the headquarters of many United Nations agencies, including the World Health Organization, and other international institutions, such as the World Trade Organization, the European Organization for Nuclear Research, the International Committee of the Red Cross and the World Economic Forum.
Every year, the World Heart Summit brings together an eclectic community of leaders and visionaries from different sectors, driven by their shared commitment to alleviate the impact of cardiovascular disease worldwide. This year, for the first time ever, members of the public are invited to join us in Geneva, Switzerland on 19-21 May. This is your opportunity to […]
We are thrilled to announce that the next edition of the World Heart Summit will take place in Geneva, Switzerland on 19-21 May 2023, ahead of the 76th World Health Assembly. The timing and location of this invitation-only event — which brings together leaders and innovators from around the world to explore the most pressing challenges in global […]
Health experts concluded a two-day World Heart Summit in Geneva on 21-22 May 2022, convened by the World Heart Federation (WHF), and urged greater efforts by all sectors to reduce cardiovascular disease, which, despite being largely preventable, claims the lives of more than 18 million people every year. “In all of your work, prioritise initiatives […]
Ahead of the 7th World Heart Summit, Professor Fausto Pinto, President of the World Heart Federation (WHF) shares his hopes and insights. He is also the Dean of the Faculty of Medicine at the University of Lisbon; and Professor of Cardiology and Head of the Cardiovascular Department, Santa Maria University Hospital/CHULN, Portugal. More than 450 […]